摘要
糖类抗原-125(CA-125)传统上被认为是肿瘤标记物,多见于上皮性卵巢肿瘤(浆液性肿瘤)患者血清中。近年来的研究表明,CA-125与心房颤动(房颤)关系密切,本文将结合最新的研究进展阐述CA-125水平与房颤风险之间的关系,旨在为临床诊疗及预测房颤风险提供依据。
Carbohydrate antigen-125(CA-125) is traditionally considered as a tumor marker,which is commonly found in the serum of patients with epithelial ovarian tumors(serous tumors).Recent studies have shown that CA-125 is closely related to atrial fibrillation(AF).This article will elaborate the latest research progress on the relationship between CA-125 level and the risk of atrial fibrillation,which aims to provide a basis for clinical diagnosis,treatment and prediction of atrial fibrillation.
作者
李梦
刘恋
吴延庆
LI Meng;LIU Lian;WU Yanqing(Department of Cardiovascular Medicine,Second Affiliated Hospital of Nanchang University,Nanchang,330000,China)
出处
《临床心血管病杂志》
CAS
北大核心
2019年第3期203-205,共3页
Journal of Clinical Cardiology
基金
国家自然科学基金(No:81660062)
关键词
糖类抗原-125
心房颤动
预测
carbohydrate antigen-125
atrial fibrillation
predict